Dr. Laterra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-9441
Education & Training
University of MichiganResidency, Neurology, 1984 - 1988
Case Western Reserve University School of MedicineClass of 1984
Certifications & Licensure
FL State Medical License 2021 - Present
MD State Medical License 1988 - 2026
PA State Medical License 2020 - 2022
MI State Medical License 1984 - 1988- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 1999 Dec 01
Publications & Presentations
PubMed
- Dynamic Glucose Enhanced Imaging using Direct Water Saturation.Linda Knutsson, Nirbhay N Yadav, Sajad Mohammed Ali, David Olayinka Kamson, Eleni Demetriou
Arxiv. 2024-10-22 - 2 citationsImpact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors.David Olayinka Kamson, Sushant Puri, Yingying Sang, Meihui Jessica Shi, Lindsay Blair
Clinical Cancer Research. 2023-12-01 - 1 citationsPreclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.Bachchu Lal, Aditya Kulkarni, Joseph McDermott, Rana Rais, Jesse Alt
Clinical Cancer Research. 2023-10-13
Journal Articles
- The Effect of the mTOR Inhibitor Rapamycin on glucoCEST Signal in a Preclinical Model of GlioblastomaJohn Laterra, MD, Magnetic Resonance in Medicine
- CEST MRI of 3‐O‐Methyl‐D‐Glucose Uptake and Accumulation in Brain TumorsJohn Laterra, MD, Magnetic Resonance in Medicine
Press Mentions
Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness MonthMay 12th, 2022- Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins During Brain Tumor Awareness MonthMay 12th, 2022
Brain Cancer's 'Immortality Switch' Turned off with CRISPRSeptember 10th, 2018- Join now to see all
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/john-laterra
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
